Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)
Clinical trial NCT05110209 · COMPLETED
Trial details
- NCT number
- NCT05110209
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-15
- Primary completion
- 2020-11-20
- Enrollment
- 331541
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.